{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-23",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "52083-051",
      "generic_name": "Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride",
      "labeler_name": "Kramer Novis",
      "brand_name": "SUPRESS DX PEDIATRIC DROPS",
      "active_ingredients": [
        {
          "name": "DEXTROMETHORPHAN HYDROBROMIDE",
          "strength": "5 mg/mL"
        },
        {
          "name": "GUAIFENESIN",
          "strength": "50 mg/mL"
        },
        {
          "name": "PHENYLEPHRINE HYDROCHLORIDE",
          "strength": "2.5 mg/mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "52083-051-01",
          "description": "1 BOTTLE in 1 CARTON (52083-051-01)  / 30 mL in 1 BOTTLE",
          "marketing_start_date": "20261006",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {},
      "marketing_category": "OTC MONOGRAPH DRUG",
      "dosage_form": "SYRUP",
      "spl_id": "2221447b-332a-44a1-8bdd-3e575558f495",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20261006",
      "product_id": "52083-051_2221447b-332a-44a1-8bdd-3e575558f495",
      "application_number": "M012",
      "brand_name_base": "SUPRESS DX PEDIATRIC DROPS",
      "pharm_class": [
        "Adrenergic alpha1-Agonists [MoA]",
        "Decreased Respiratory Secretion Viscosity [PE]",
        "Expectorant [EPC]",
        "Increased Respiratory Secretions [PE]",
        "Sigma-1 Agonist [EPC]",
        "Sigma-1 Receptor Agonists [MoA]",
        "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]",
        "Uncompetitive NMDA Receptor Antagonists [MoA]",
        "alpha-1 Adrenergic Agonist [EPC]"
      ]
    }
  ]
}